Product Information
XADAGO 50 MG TABLET is a brand product labeled by MDD US Operations LLC, a subsidiary of Supernus Pharmaceuticals, Inc., priced at $36.4150 per EA under NDC 27505011030. Its NADAC has been published 115 times since Apr 17, 2024.
Strength
50 mg/1
NDC
27505011030
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
1/21/2026
Active Ingredients
SAFINAMIDE MESYLATEApproval Type
New Drug (NDA)
FDA Application
NDA207145On Market Since
5/8/2017
Pharmacological Classes
Price Statistics
The NADAC for XADAGO 50 MG TABLET has been published 115 times since Apr 17, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $36.4150 per EA |
|---|---|
| All-time high | $36.5587 (Oct 16, 2024) |
| All-time low | $36.4150 (Dec 17, 2025) |
| 52-week high | $36.4682 |
| 52-week low | $36.4150 |
| Median price | $36.4682 |
| Average price | $36.4926 |
| Largest weekly change | -0.2% (May 21, 2025) |
| Weeks tracked | 115 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the safinamide mesylate market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of XADAGO 50 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for XADAGO 50 MG TABLET, manufactured by MDD US Operations LLC, a subsidiary of Supernus Pharmaceuticals, Inc., is $36.4150 per EA (NDC 27505011030), effective Jun 24, 2026.
How has the price of XADAGO 50 MG TABLET changed over time?
Over the history we have for it, the NADAC for XADAGO 50 MG TABLET has held within roughly two percent of its current level. It has been tracked across 115 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for XADAGO 50 MG TABLET?
Since Apr 17, 2024, the NADAC for XADAGO 50 MG TABLET has ranged from a low of $36.4150 (Dec 17, 2025) to a high of $36.5587 (Oct 16, 2024), with a median of $36.4682 per EA.
Are there cheaper alternatives to XADAGO 50 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of XADAGO 50 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures XADAGO 50 MG TABLET?
XADAGO 50 MG TABLET (NDC 27505011030) is labeled by MDD US Operations LLC, a subsidiary of Supernus Pharmaceuticals, Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification